沈颗粒用于败血症患者:多中心,随机,双盲,安慰剂控制的临床试验的研究方案

Meng-Yuan Shen1, Ze-Jiong Li1, Dan-Dan Feng2

  • 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.

Frontiers in medicine
|December 8, 2025
PubMed
概括

这项研究评估了沈黄颗粒 (SHG) 用于败血症治疗. 随机对照试验的目的是确定SHG是否可以改善毒症患者的生存率并减少毒症患者的并发症.